AABB shapes legislative and regulatory policies that support safety and innovation. The Association engages policymakers, providers, suppliers, manufacturers and patient groups to promote patient and donor care and safety in transfusion medicine and cellular therapies.
HHS Publishes Report to Congress on the Adequacy of the Blood Supply
February 17, 2021
Lawmakers Introduce Black Maternal Health ‘Momnibus’ Act
February 10, 2021
AABB Releases Findings From 2021 Survey of Hospital Transfusion Services
February 01, 2021